| class="wikitable"
|+Awards |
| Year | Recipient | Lecture title |
|---|
| 1982 | Sir Mark Richmond | β-Lactamases: are they really important? |
| 1983 | F W O'Grady | Strategies for potentiating chemotherapy in severe sepsis: some experimental pointers. |
| 1984 | Sir Charles Stuart-Harris | Strategies of antiviral chemotherapy. |
| 1985 | Naomi Datta | Antidotes of bacteria to antibacterial drugs |
| 1986 | Sir Edward P Abraham | β-Lactamase antibiotics: motivation, science and luck in their past and future |
| 1987 | George N. Rolinson[{{cite journal |last1=Geddes |first1=Alasdair M. |title=Dr George N. Rolinson, 16 March 1926–8 December 2016 |journal=Journal of Antimicrobial Chemotherapy |date=July 2017 |volume=72 |issue=7 |pages=1847 |doi=10.1093/jac/dkx075 |url=https://academic.oup.com/jac/article/72/7/1847/3067740|doi-access=free |url-access=subscription }}] | The influence of 6-aminopenicillanic acid on antibiotic development. |
| 1990 | Robert C. Moellering Jr[{{cite journal |last1=Rice |first1=Louis B. |last2=Eliopoulos |first2=George M. |last3=Jacoby |first3=George A. |title=In Memoriam: Robert C. Moellering, Jr. |journal=Antimicrobial Agents and Chemotherapy |date=July 2014 |volume=58 |issue=7 |pages=3583–3584 |doi=10.1128/AAC.03199-14 |pmid=24798286 |pmc=4068561 |issn=0066-4804}}][{{cite book |last1=Saag |first1=Michael S. |title=Updates in HIV and AIDS: Part I, An Issue of Infectious Disease Clinics |date=2014 |publisher=Elsevier |location=Philadelphia |isbn=978-0-323-32328-4 |page=xiv |url=https://books.google.com/books?id=MqBlBAAAQBAJ&dq=%22garrod+medal%22&pg=PR14 |language=en}}] | The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. |
| 1991 | Denis Mitchison | Understanding the chemotherapy of tuberculosis - current problems. |
| 1999 | Alasdair Geddes | Infection in the 21st Century - and possible implications for therapy. |
| 2009 | Sir Richard Sykes | The evolution of antimicrobial resistance: a Darwinian perspective |
| 2011 | Brian Spratt[{{cite web |title=Honours and Memberships - Professor Brian G Spratt FRS |url=https://www.imperial.ac.uk/people/b.spratt/honours-and-memberships.html |website=www.imperial.ac.uk |access-date=5 November 2021}}] | My 40 years - from penicillin-binding proteins to molecular epidemiology. Given during the BSAC 40th anniversary scientific Spring Meeting |
| 2012 | Ian Chopra[{{cite web |title=Ian Chopra {{!}} School of Molecular and Cellular Biology {{!}} University of Leeds |url=https://biologicalsciences.leeds.ac.uk/molecular-and-cellular-biology/staff/274/ian-chopra |website=biologicalsciences.leeds.ac.uk |access-date=5 November 2021 |language=en}}] | Discovery of anti-bacterial drugs in the twenty-first century |
| 2016 | John E. McGowan Jr[{{cite web |title=2017 Commencement |url=https://www.sph.emory.edu/rollins-life/events/commencement/archives/2017/index.html |website=www.sph.emory.edu |access-date=2 November 2021}}] | The role of the healthcare epidemiologist in antimicrobial chemotherapy—a view from the USA |
| 2017 | Peter Hawkey[{{cite news |title=Birmingham researchers awarded the Garrod Medal and the Gilbert Blane Medal |url=https://www.birmingham.ac.uk/university/colleges/mds/news/2018/02/hawkey-oshea-awards.aspx |access-date=2 November 2021 |work=University of Birmingham}}] | Genes, guts and globalization |
| 2018 | David Livermore | The Black Swans of Resistance |
| 2019 | Laura Piddock | MDR efflux in Gram-negative bacteria—how understanding resistance led to a new tool for drug discovery |